Liquid Biopsy as a Tool to Evaluate Resistance to First and Third (AZD9291) (EGFR) (TKIs) in (EGFR) Mutant NSCLC
Clinical trial NCT02771314 · UNKNOWN
Trial details
- NCT number
- NCT02771314
- Sponsor
- Hellenic Oncology Research Group
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-02
- Primary completion
- 2020-06-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.